Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells
Author(s) -
Gioele La Manno,
Daniel Gyllborg,
Simone Codeluppi,
Kaneyasu Nishimura,
Carmen Saltó,
Amit Zeisel,
Lars E. Borm,
Simon Stott,
Enrique M. Toledo,
J. Carlos Villaescusa,
Peter Lönnerberg,
Jesper Ryge,
Roger A. Barker,
Ernest Arenas,
Sten Linnarsson
Publication year - 2016
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2016.09.027
Subject(s) - biology , midbrain , stem cell , diversity (politics) , evolutionary biology , microbiology and biotechnology , genetics , neuroscience , central nervous system , sociology , anthropology
Understanding human embryonic ventral midbrain is of major interest for Parkinson's disease. However, the cell types, their gene expression dynamics, and their relationship to commonly used rodent models remain to be defined. We performed single-cell RNA sequencing to examine ventral midbrain development in human and mouse. We found 25 molecularly defined human cell types, including five subtypes of radial glia-like cells and four progenitors. In the mouse, two mature fetal dopaminergic neuron subtypes diversified into five adult classes during postnatal development. Cell types and gene expression were generally conserved across species, but with clear differences in cell proliferation, developmental timing, and dopaminergic neuron development. Additionally, we developed a method to quantitatively assess the fidelity of dopaminergic neurons derived from human pluripotent stem cells, at a single-cell level. Thus, our study provides insight into the molecular programs controlling human midbrain development and provides a foundation for the development of cell replacement therapies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom